4 May 2016PHARMAC is seeking feedback by 25 May 2016 on a proposal to fund nivolumab (Opdivo) for patients with unresectable or metastatic melanoma. The MelNet Executive Committee feedback to PHARMAC can be found here.
26 April 2016This report provides a useful snapshot in time of New Zealand researchers and the research they are conducting into the control or understanding of melanoma.
13 April 2016A University of Otago study that involved unobtrusively observing the sun-protective practices of students and staff at the sports days of 10 Dunedin secondary schools last summer has found them sorely lacking.
9 April 201650 per cent of secondary schools with a sun protection policy scored significantly better than other schools, according to study carried out by Cancer Society Social and Behavioural Research Unit staff.
30 March 2016A new study has found New Zealand has overtaken Australia as having the highest per capita rates of invasive melanoma in the world.
18 March 2016The public will support increased
regulation of indoor tanning due to public awareness of its link to skin
cancer, according to authors of this study.
14 March 2016“With advancements of improving molecular
assays, liquid biopsy analysis as a powerful, routine clinical assay for
melanoma patients, is highly promising prospective”, according to a recent
study.
12 March 2016
A thorough risk-benefit evaluation should
always be done before UV treatment, according to authors of a study in a Mediterranean
population. The authors advise
clinicians to carefully monitor patients for skin cancer during and after
treatment discontinuation.
11 March 2016Tanning salons in the US actively
use social media as a strategy for maintaining relationships with customers and
offer pricing deals that promote loyalty and high-frequency tanning, according
to authors of a recent study.
8 March 2016
“Physicians and patients should not rely on
the total nevus count as a sole reason to perform skin examinations or to determine
a patient’s at-risk status”, according to authors of a recent study. They also conclude “younger patients should
be educated on the increased risk of thicker melanomas that is associated with
having more atypical nevi”.